MarketInOut Stock Screener Log In | Sign Up

Cipla Ltd

BSE • Healthcare • Drug Manufacturers - General • Quote as of 10/28/2026 10:01
Cipla Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeBSE
Market Capitalization1,090,504 mln
Float556 mln
Earnings Date10/27/2026

EPS

56.20
Exceptional

P / E

23.86
Premium valuation

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-2.39
Borderline

Relative Strength

84 / 100
Strongly outperforming

Debt / Equity

0.02
Debt-free

Business Description

Founded in 1935 and headquartered in Mumbai, India, Cipla Limited is a global pharmaceutical company that makes and sells a wide range of medicines across India, the United States, South Africa, and other markets. The company produces generic and branded drugs, vaccines, and active pharmaceutical ingredients covering treatments for conditions such as heart disease, diabetes, HIV/AIDS, cancer, respiratory illness, and many others. Beyond its core pharmaceutical business, Cipla also operates in consumer healthcare, biosimilars, and specialty medicine.

Key Fundamentals

EPS56.20
P/E23.86
ROE10.29
RPS346
ROIC11.13
ROA8.45
Interest Cover71.06
EBITDA, mln58,555
EV / EBITDA17.08
EV / EBIT21.78
Revenue, mln283,244
EV / Revenue3.53

Quote Details

Last 1,348.20
Change -1.8 (-0.13%)
Open 1,335.20
Volume 15,309
Turnover 20,639,594
Average Volume 44,013

Financial Ratios

Pre-Tax Profit Margin16
Current Ratio3.44
Price / Book3.17
Price / Tangible Book3.96
Price / Cash Flow81.04
Price / Free Cash Flow42.80
Debt / Equity0.02
Price / Sales3.86
PEG Ratio2.74

Financial Strength

Altman Z-Score10.66
Piotroski F-Score 3 / 9
Beneish M-Score-2.39
Price to Intrinsic Value1.63
Price to Lynch Fair Value2.56
Price to Graham Number2.17
Shiller PE Ratio34.22

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.62% 81 / 100   
1 Month -3.51% 69 / 100   
2 Months -5.89% 58 / 100   
6 Months 3.44% 68 / 100   
1 Year -13.76% 54 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog